Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
12.79
+0.24 (1.91%)
At close: Dec 5, 2025, 4:00 PM EST
12.90
+0.11 (0.86%)
After-hours: Dec 5, 2025, 7:48 PM EST
Arvinas Employees
Arvinas had 430 employees as of December 31, 2024. The number of employees decreased by 15 or -3.37% compared to the previous year.
Employees
430
Change (1Y)
-15
Growth (1Y)
-3.37%
Revenue / Employee
$726,279
Profits / Employee
-$136,047
Market Cap
821.43M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ARVN News
- 13 hours ago - Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition - GlobeNewsWire
- 10 days ago - Arvinas to Present at Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 12 days ago - Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS) - GlobeNewsWire
- 4 weeks ago - Arvinas, Inc. (ARVN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting - GlobeNewsWire
- 4 weeks ago - Arvinas to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Arvinas to Report Third Quarter 2025 Financial Results on November 5, 2025 - GlobeNewsWire